Latest News

Payer/Managed Markets Five things for pharma marketers to know: Friday, August 28

Five things for pharma marketers to know: Friday, August 28

Amgen's Repatha receives FDA nod; Mylan shareholders vote in favor of Perrigo deal; doctors push for below-average price of experimental cancer drug

At Work With At Work With . . . Joe Doyle

At Work With . . . Joe Doyle

Pipeline The FDA approves second PCSK9 inhibitor, Repatha

The FDA approves second PCSK9 inhibitor, Repatha

Amgen's Repatha will come to market priced $500 lower than the cost of Sanofi and Regeneron's Praluent.

Campaigns Sunovion prepares for FDA decision on Aptiom

Sunovion prepares for FDA decision on Aptiom

The FDA is expected to announce this week whether it has approved the epilepsy drug as a monotherapy for partial-onset seizures.

Legal/Regulatory Five things for pharma marketers to know: Thursday, August 27

Five things for pharma marketers to know: Thursday, August 27

The FDA releases biosimilar-naming draft guidance; PD1 drugs linked to a rare type of diabetes; Amgen's PCSK9 inhibitor faces approval decision

Agency CHC and CCC partner to offer regulatory education to agencies

CHC and CCC partner to offer regulatory education to agencies

The compliance "university" aims to help healthcare agencies and publishers stay up to date on the latest regulatory changes.

Payer/Managed Markets Five things for pharma marketers to know: Wednesday, August 26

Five things for pharma marketers to know: Wednesday, August 26

Medicaid officials urged to expand access to hepatitis-C drugs; Perrigo is looking to make acquisitions; Sarepta's experimental therapy gets priority review

Pipeline Diabetes device firm Intarcia taps former ICC Lowe CEO Viviano as marketing lead

Diabetes device firm Intarcia taps former ICC Lowe CEO Viviano as marketing lead

Longtime ICC leader Viviano moves to the client side to help the start-up build its marketing team and become a commercial contender.

Corporate Inovalon scoops up consultancy Avalere Health

Inovalon scoops up consultancy Avalere Health

The cloud technology firm announced it will acquire Avalere in a move aimed at growing its relationships with pharma.

In Depth

In Depth

Social Engagement: Leveling the Field

Brand Development Strategies: Golden Oldies

Mobile Marketing: Dial M for Launch

Professional Ad Report: Staying Power

Therapeutic Focus: Women's Health

Back Talk: Is Cost Myopia Unfocused?

Private View: The Lions Share